In heterogeneous catalysis, the catalyst is in a different phase from the reactants. Application In Synthesis of Mofezolac, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 78967-07-4, name is Mofezolac. In an article，Which mentioned a new discovery about 78967-07-4
The invention relates to a new class of compounds of formula (I) targeting COX-1. The invention also relates to the use of some of such compounds as a tool to investigate the structure and function of the enzyme, in the treatment targeting COX-1 or detection of COX-1 in relating disorders or diseases such as cancer and neuroinflammation, in particular in neurological (e.g. autism spectrum disorders) and neurodegenerative diseases (e.g. Alzheimer’s diseases, Parkinson’s diseases, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), traumatic brain injury (TBI), HIV dementia and prion diseases), and in gynecological tumour (e.g. ovarian cancer), neck and head tumor, and haematological tumours (e.g. multiple myeloma) and in the detection of COX-1 in “in vitro” (cells and tissues) and in “in vivo”.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 78967-07-4, help many people in the next few years.Application In Synthesis of Mofezolac
Reference：
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem